XML 41 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expenses
The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations:

Three months ended
March 31,
(in thousands)
20242023
Cost of revenue
$766 $1,011 
Research and development7,666 2,683 
General and administrative7,077 4,578 
Total$15,509 $8,272 
Schedule of Share-based Payment Arrangement, Option, Activity
Stock option activity during the three months ended March 31, 2024 was as follows:

 (in thousands except share and per share amounts)
Shares 
Weighted-Average Exercise
Price
Weighted-Average Remaining Contractual Life (in years)
Aggregate Intrinsic Value
Outstanding as of December 31, 202314,957,617 $6.13 7.0$72,416 
Granted2,558,102 10.09 
Cancelled(178,609)12.70 
Exercised(1,303,878)2.80 11,575 
Outstanding as of March 31, 202416,033,232 $6.99 7.3$64,131 
Exercisable as of March 31, 20248,909,647 $5.49 6.2$51,959 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following weighted-average assumptions were used to calculate the grant-date fair value of stock options:

Three months ended March 31,
 20242023
Expected term (in years)
6.36.3
Expected volatility
65 %64 %
Expected dividend yield
— — 
Risk-free interest rate
4.2 %3.5 %
Schedule of Nonvested RSU Activity
The following table summarizes Recursion’s RSU activity during the three months ended March 31, 2024:

Stock unitsWeighted-average grant date fair value
Outstanding as of December 31, 202315,223,764 $8.39 
Granted1,840,877 10.46 
Vested(1,023,464)8.60 
Forfeited(409,634)7.99 
Outstanding as of March 31, 202415,631,543 $8.63